Anaplastic ganglioglioma—A diagnosis comprising several distinct tumour types

Anaplastic ganglioglioma is a rare tumour, and diagnosis has been based on histological criteria. The 5th edition of the World Health Organization Classification of Tumours of the Central Nervous System (CNS WHO) does not list anaplastic ganglioglioma as a distinct diagnosis due to lack of molecular data in previous publications. We retrospectively compiled a cohort of 54 histologically diagnosed anaplastic gangliogliomas to explore whether the molecular profiles of these tumours represent a separate type or resolve into other entities.

[1]  C. Cadwell,et al.  Targeted Next-Generation Sequencing Reveals Divergent Clonal Evolution in Components of Composite Pleomorphic Xanthoastrocytoma-Ganglioglioma. , 2022, Journal of Neuropathology and Experimental Neurology.

[2]  S. Bens,et al.  Low‐grade diffusely infiltrative tumour (LGDIT), SMARCB1‐mutant: A clinical and histopathological distinct entity showing epigenetic similarity with ATRT‐MYC , 2022, Neuropathology and applied neurobiology.

[3]  David C. Jones,et al.  Pleomorphic xanthoastrocytoma is a heterogeneous entity with pTERT mutations prognosticating shorter survival , 2022, Acta Neuropathologica Communications.

[4]  S. Pfister,et al.  A Summary of the Inaugural WHO Classification of Pediatric Tumors: Transitioning from the Optical into the Molecular Era , 2021, Cancer discovery.

[5]  David C. Jones,et al.  Recurrent fusions in PLAGL1 define a distinct subset of pediatric-type supratentorial neuroepithelial tumors , 2021, Acta Neuropathologica.

[6]  I. Blümcke,et al.  Integrated genotype–phenotype analysis of long‐term epilepsy‐associated ganglioglioma , 2021, Brain pathology.

[7]  Marilyn M. Li,et al.  The spectrum of rare central nervous system (CNS) tumors with EWSR1‐non‐ETS fusions: experience from three pediatric institutions with review of the literature , 2020, Brain pathology.

[8]  K. Aldape,et al.  cIMPACT‐NOW update 7: advancing the molecular classification of ependymal tumors , 2020, Brain pathology.

[9]  David T. W. Jones,et al.  Histone H3 wild-type DIPG/DMG overexpressing EZHIP extend the spectrum diffuse midline gliomas with PRC2 inhibition beyond H3-K27M mutation , 2020, Acta Neuropathologica.

[10]  D. Ellison,et al.  Tectal glioma harbors high rates of KRAS G12R and concomitant KRAS and BRAF alterations , 2019, Acta Neuropathologica.

[11]  David T. W. Jones,et al.  Rosette-forming glioneuronal tumors share a distinct DNA methylation profile and mutations in FGFR1, with recurrent co-mutation of PIK3CA and NF1 , 2019, Acta Neuropathologica.

[12]  A. Iafrate,et al.  PIK3CA activating mutations are associated with more disseminated disease at presentation and earlier recurrence in glioblastoma , 2019, Acta Neuropathologica Communications.

[13]  M. Honavar,et al.  Review: Challenges in the histopathological classification of ganglioglioma and DNT: microscopic agreement studies and a preliminary genotype‐phenotype analysis , 2018, Neuropathology and applied neurobiology.

[14]  M. Berger,et al.  The genetic landscape of anaplastic pleomorphic xanthoastrocytoma , 2018, Brain pathology.

[15]  Stefan M. Pfister,et al.  Routine RNA sequencing of formalin-fixed paraffin-embedded specimens in neuropathology diagnostics identifies diagnostically and therapeutically relevant gene fusions , 2019, Acta Neuropathologica.

[16]  T. Maruyama,et al.  Role of a Promoter Mutation in TERT in Malignant Transformation of Pleomorphic Xanthoastrocytoma. , 2019, World neurosurgery.

[17]  Jinsong Wu,et al.  BRAF V600E, TERT, and IDH2 Mutations in Pleomorphic Xanthoastrocytoma: Observations from a Large Case-Series Study. , 2018, World neurosurgery.

[18]  C. Drissi,et al.  Pediatric Intracranial Anaplastic Gangliogliomas: Illustrative Case and Systematic Review. , 2018, World neurosurgery.

[19]  Diane D. Liu,et al.  Ganglioglioma in children and young adults: single institution experience and review of the literature , 2018, Journal of Neuro-Oncology.

[20]  G. Rath,et al.  Impact of surgery, adjuvant treatment, and other prognostic factors in the management of anaplastic ganglioglioma , 2018, Child's Nervous System.

[21]  David T. W. Jones,et al.  Anaplastic astrocytoma with piloid features, a novel molecular class of IDH wildtype glioma with recurrent MAPK pathway, CDKN2A/B and ATRX alterations , 2018, Acta Neuropathologica.

[22]  Till Acker,et al.  DNA methylation-based classification of central nervous system tumours , 2018, Nature.

[23]  P. Varlet,et al.  Co‐occurrence of histone H3 K27M and BRAF V600E mutations in paediatric midline grade I ganglioglioma , 2018, Brain pathology.

[24]  B. Taylor,et al.  Tumours with class 3 BRAF mutants are sensitive to the inhibition of activated RAS , 2017, Nature.

[25]  David T. W. Jones,et al.  Molecular Transition of an Adult Low-Grade Brain Tumor to an Atypical Teratoid/Rhabdoid Tumor Over a Time-Course of 14 Years , 2017, Journal of neuropathology and experimental neurology.

[26]  David T. W. Jones,et al.  H3-/IDH-wild type pediatric glioblastoma is comprised of molecularly and prognostically distinct subtypes with associated oncogenic drivers , 2017, Acta Neuropathologica.

[27]  P. Varlet,et al.  K27M mutation in H3F3A in ganglioglioma grade I with spontaneous malignant transformation extends the histopathological spectrum of the histone H3 oncogenic pathway , 2017, Neuropathology and applied neurobiology.

[28]  E. Mandonnet,et al.  Natural course and prognosis of anaplastic gangliogliomas: a multicenter retrospective study of 43 cases from the French Brain Tumor Database , 2016, Neuro-oncology.

[29]  B. Devaux,et al.  Clinical, Imaging, Histopathological and Molecular Characterization of Anaplastic Ganglioglioma , 2016, Journal of neuropathology and experimental neurology.

[30]  G. Reifenberger,et al.  The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary , 2016, Acta Neuropathologica.

[31]  Stefan M. Pfister,et al.  Next-generation sequencing in routine brain tumor diagnostics enables an integrated diagnosis and identifies actionable targets , 2016, Acta Neuropathologica.

[32]  S. Tatter,et al.  Anaplastic ganglioglioma: a report of three cases and review of the literature , 2015, Journal of Neuro-Oncology.

[33]  P. Varlet,et al.  Evidence for BRAF V600E and H3F3A K27M double mutations in paediatric glial and glioneuronal tumours , 2015, Neuropathology and applied neurobiology.

[34]  A. Magi,et al.  Genome-wide copy number analysis in pediatric glioblastoma multiforme. , 2014, American journal of cancer research.

[35]  Diane D. Liu,et al.  Clinical and prognostic features of adult patients with gangliogliomas. , 2013, Neuro-oncology.

[36]  David T. W. Jones,et al.  ATRX and IDH1-R132H immunohistochemistry with subsequent copy number analysis and IDH sequencing as a basis for an “integrated” diagnostic approach for adult astrocytoma, oligodendroglioma and glioblastoma , 2014, Acta Neuropathologica.

[37]  M. Jenkinson,et al.  Outcome and prognostic features in anaplastic ganglioglioma: analysis of cases from the SEER database , 2011, Journal of Neuro-Oncology.

[38]  Süleyman Cenk Sahinalp,et al.  deFuse: An Algorithm for Gene Fusion Discovery in Tumor RNA-Seq Data , 2011, PLoS Comput. Biol..

[39]  A. Ashworth,et al.  A Distinct Spectrum of Copy Number Aberrations in Pediatric High-Grade Gliomas , 2010, Clinical Cancer Research.

[40]  A. Hoischen,et al.  Comprehensive Characterization of Genomic Aberrations in Gangliogliomas by CGH, Array‐based CGH and Interphase FISH , 2008, Brain pathology.

[41]  P. Shannon,et al.  Malignant and benign ganglioglioma: a pathological and molecular study. , 2007, Neuro-oncology.

[42]  R. McLendon,et al.  Mutations of PIK3CA in Anaplastic Oligodendrogliomas, High-Grade Astrocytomas, and Medulloblastomas , 2004, Cancer Research.

[43]  R. Fimmers,et al.  Supratentorial gangliogliomas: Histopathologic grading and tumor recurrence in 184 patients with a median follow‐up of 8 years , 2004, Cancer.

[44]  P. Liberski,et al.  Pleomorphic xanthoastrocytoma with a gangliomatous component: an immunohistochemical and ultrastructural study , 2004, Acta Neuropathologica.

[45]  I. Blümcke,et al.  Gangliogliomas: An Intriguing Tumor Entity Associated With Focal Epilepsies , 2002, Journal of neuropathology and experimental neurology.

[46]  A. Poustka,et al.  Comprehensive Allelotype and Genetic Analysis of 466 Human Nervous System Tumors , 2000, Journal of neuropathology and experimental neurology.

[47]  M. Mizuguchi,et al.  Novel Cerebral Lesions in the Eker Rat Model of Tuberous Sclerosis: Cortical Tuber and Anaplastic Ganglioglioma , 2000, Journal of neuropathology and experimental neurology.

[48]  B. Scheithauer,et al.  Composite pleomorphic xanthoastrocytoma and ganglioglioma: report of four cases and review of the literature. , 1997, The American journal of surgical pathology.